SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference, and invited investors to participate via webcast. Morgan Stanley Annual Global Healthcare Conference in New York, NYThursday, September 13, 2018 at 1:30pm Eastern Time The live webcast can be accessed in the Investor Relations section of Illumina’s... Read more
The Waters Xevo TQ-GC Mass Spectrometer and Restek Gas Chromatography Consumables Are a Winning Combination for Routine GC-MS Pesticide Residue Analyses and Screening MILFORD, Mass.–(BUSINESS WIRE)–Aug. 28, 2018– Waters Corporation (NYSE:WAT) and Restek Corporationhave entered into a co-marketing agreement in an effort to give food safety laboratories access to the GC-MS instrumentation and consumables they need to perform... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced that its MiSeq™Dx Sequencing System received the approval certificate from the China National Drug Administration (CNDA). This is Illumina’s first CNDA-cleared, next-generation sequencing (NGS) system in China. In accordance with the clearance, Illumina can now market and sell the MiSeqDx Sequencing System to hospitals and other medical institutions... Read more
Thermo Scientific FAIMS Pro device delivers selectivity and productivity in high-resolution mass spectrometry FLORENCE, Italy, Aug. 27, 2018 /PRNewswire/ — IMSC 2018 – Proteomic scientists can now take advantage of a next-generation differential ion mobility device that seamlessly integrates with high-resolution mass spectrometers to provide workflow efficiency and data quality for experiments ranging from the discovery of... Read more
— Bruker’s MALDI Biotyper and IR Biotyper microbiology platforms to be complemented by innovative Hain solutions for molecular diagnostics (MDx) of bacterial and viral infections — Acquisition to expand Bruker’s presence in attractive microbiology and virology infectious disease MDx markets, in support of Bruker’s portfolio transformation — Hain to add expertise in tuberculosis and mycobacteria... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–Aug. 23, 2018– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the 16th annual Morgan Stanley Global Healthcare Conference on Friday, September 14, 2018 at 11:40 a.m. ET at the Grand Hyatt New York in New York City. Robert... Read more
AUG 22, 2018 Download PDF Agilent’s wholesale shift in its allegations, two and a half years into its suit, reveals only the weakness of its claims. Agilent’s most recent allegations are gamesmanship, not substance. They omit that more than four months before it sought to change its complaint, Twist informed – and provided to Agilent – the... Read more
Shimadzu Corporation announces the release of IMAGEREVEAL MS mass spectrometry imaging data analysis software. The software simplifies the data analysis process by enabling data to be analyzed from a variety of perspectives, without requiring any extra time or trouble. It is especially well-suited to analyzing large sets of data or simultaneously analyzing multiple sets of... Read more
21 August 2018 Combining LabChip® GX Touch Nucleic Acid Analyzer and MassARRAY® for Optimized Liquid Biopsy Workflow San Diego, CA – Agena Bioscience (Agena) announced today that they have entered into a collaboration with PerkinElmer, incorporating the LabChip® GX Touch™ nucleic acid analyzer for quality assessment and quantitation of DNA in the upfront workflow of Agena’s MassARRAY®system. The... Read more
Agilent Companion Diagnostic Gains Expanded FDA Approval in Urothelial Carcinoma PD-L1 IHC 22C3 pharmDx Now Approved to Identify Certain Urothelial Carcinoma Patients for Treatment With KEYTRUDA(R) (pembrolizumab) SANTA CLARA, Calif., August 21, 2018 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved its Dako PD-L1 IHC 22C3... Read more